pyrazinamide has been researched along with Opportunistic Infections in 5 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There have been only 2 case reports of peritoneal tuberculosis associated with anti-TNF and only 1 with adalimumab." | 1.35 | Tuberculous peritonitis after treatment with adalimumab. ( Antolín, J; Azahara, M; Blanco, M; Cigüenza, R; Hernández, C; Mao, L, 2008) |
| "A patient with Hodgkin's disease (HD) underwent autologous bone marrow transplantation (ABMT)." | 1.29 | Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. ( Ackerstein, A; Engelhard, D; Gazit, D; Kupolovicz, U; Nagler, A; Or, R; Raveh, D; Toren, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, S | 1 |
| Weaver, MD | 1 |
| Roy, S | 1 |
| Antolín, J | 1 |
| Azahara, M | 1 |
| Hernández, C | 1 |
| Blanco, M | 1 |
| Mao, L | 1 |
| Cigüenza, R | 1 |
| Sattinger, E | 1 |
| Meyer, S | 1 |
| Costard-Jäckle, A | 1 |
| Siu, YP | 1 |
| Tong, MK | 1 |
| Leung, KT | 1 |
| Yung, CY | 1 |
| Toren, A | 1 |
| Ackerstein, A | 1 |
| Gazit, D | 1 |
| Or, R | 1 |
| Raveh, D | 1 |
| Kupolovicz, U | 1 |
| Engelhard, D | 1 |
| Nagler, A | 1 |
5 other studies available for pyrazinamide and Opportunistic Infections
| Article | Year |
|---|---|
Miliary tuberculosis and herpes pharyngitis after a trip to a developing country: dangers of biologics.
Topics: Adalimumab; Aged, 80 and over; Anti-Bacterial Agents; Antirheumatic Agents; Antitubercular Agents; A | 2018 |
Tuberculous peritonitis after treatment with adalimumab.
Topics: Adalimumab; Aged; Antibiotics, Antitubercular; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2008 |
Cutaneous tuberculosis mimicking erysipelas of the lower leg in a heart transplant recipient.
Topics: Antitubercular Agents; Erysipelas; Ethambutol; Heart Transplantation; Humans; Isoniazid; Leg; Opport | 2011 |
Successful kidney re-transplantation in a patient with previous allograft kidney tuberculosis.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Immunosuppression Therapy; Isoniazid; Kidney Trans | 2004 |
Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Antitubercular Agents; Bone Marrow Transplanta | 1996 |